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It has been said that a week is a long
time in politics. But in human disease gene
mapping, 10 years can seem a very short
time indeed. It once seemed so simple: find
a family with a number of affected
individuals and narrow down regions of
the genome shared by affected individuals
but not their unaffected siblings. This
process (family linkage analysis) was
lengthy but had notable success with some
diseases, including hereditary breast can-
cers caused by the BRCA1 and BRCA2
genes. Yet, many diseases known to have a
genetic component (because they tend to
run in families or siblings show a high
concordance) do not follow a simple
Mendelian pattern of inheritance and
cannot be dissected in this way. Instead,
researchers tried an ‘‘association’’ ap-
proach, starting with a large number of
unrelated individuals, to find gene vari-
ants, or alleles, that are more common in
affected than in unaffected controls. For
such a strategy to work, the diseases must
be influenced by variants that are quite
common in the populations.
Some readers might recall the heated
debates about the common disease, com-
mon variant (CD-CV) hypothesis. Using
arguments based on population genetics
(such as the rate of creation and purging of
deleterious alleles, the genetic bottleneck
in the human population and subsequent
population expansion) [1], the CD-CV
hypothesis proposed that in common
diseases with a genetic component, some
predisposing alleles are relatively common
and a combination of alleles or environ-
mental effects was required before disease
occurred, much like being dealt a bad
hand from a common deck of cards.
Under this hypothesis, disease-associated
alleles might be found by using common
gene variants, such as single nucleotide
polymorphisms (SNPs), as a guide and
comparing affected individuals with con-
trols. Others cast doubt on this idea and
suggested that common diseases are un-
likely to be caused by common alleles and
more likely to be caused by rarer ones;
they too deployed arguments based on
population genetics and suggested that
association studies using common genetic
variants might not be successful [2,3]. As
with all scientific debates, there seemed
only one way out: collect the data and see.
Well, 10 years and several millions of
dollars later we have a lot of data, but are
we any the wiser? Do we understand the
allelic spectrum of disease any better than
we did 10 years ago?
There have now been over 700 ge-
nome-wide association studies (GWAS)
published linking many variants to over a
hundred diseases [4]. Many of these results
are robust in that they can be replicated in
several populations, leaving little doubt
that common variants can contribute to
common diseases. The problem is that the
effect of these variants on disease is often
rather modest, so that people with the
disease-predisposing alleles are only slight-
ly more likely to get the disease than those
without. Larger and larger studies reveal
more disease genes, usually with smaller
and smaller effect on overall disease risk.
The ‘‘missing heritability’’ problem then
arises because, even in aggregate, these
loci typically fall somewhat short of
explaining the entire genetic component
of disease risk. So where are the genes
accounting for major predisposition to
disease? One possible explanation is that
GWAS do not directly reveal the disease-
causative DNA variant, but rather a
common DNA variant (usually an SNP)
that is close enough to be genetically
linked to it (almost always inherited
together) and common enough to be on
the genotyping microarrays. This has
spurred more effort (and more expense)
to find rarer and rarer SNPs by sequenc-
ing more genomes and make even larger
arrays in the hope that the new SNPs may
be in even closer linkage with the causative
allele. Alternatively, it’s possible that the
disease-predisposing variants are not SNPs
at all, but other changes in the genome,
such as a duplicated or deleted gene or
region—a so-called copy number variant
(CNV)—or a result of epigenetic marks in
the chromatin; neither of these would
show up using the current generation of
microarrays that look just at SNPs.
A paper published recently in PLoS
Biology [5] from the lab of David Goldstein
put the cat amongst the CD-CV pigeons
by suggesting that rather than common
diseases being caused by common alleles,
maybe rare alleles each with a large effect
on disease might be creating ‘‘synthetic
associations’’ in the GWAS signal by
occurring, by chance, more often with
one common allele than another. The
paper used statistical reasoning to suggest
that such synthetic associations are possi-
ble—but are they likely? Given how much
time and money has been invested in
surveying SNPs and attempting to match
them up to diseases, the relative impor-
tance of such synthetic associations would
have important implications on the direc-
tion of future research. The paper got a lot
of publicity, even making the New York
Times [6].
Now, some might say that no one likes
the implication that they have been
barking up the wrong scientific tree, still
less perhaps that such a critique garnered
a lot of publicity. But the issue is best
settled by discussion—and data—which is
why in this issue of PLoS Biology we publish
two critiques of the original article [7,8]
together with a response from the original
authors [9]. The critiques argue that
although rare variants could in theory
create synthetic associations, this is not a
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bility. Perhaps with further advances in
ever cheaper sequencing technologies and
the ability to sequence whole genomes
from affected individuals we will, before
the next 10 years are up, finally have a
better understanding of the missing pieces
of the genetic causes of common disease.
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